What Are Hepatic Disorders?
Hepatic (liver) disorders encompass a wide range of acute and chronic conditions affecting the liver — the body's largest internal organ responsible for detoxification, protein synthesis, bile production, fat metabolism, and glucose regulation. India bears one of the highest burdens of liver disease globally, with over 220 million people affected by fatty liver disease and 40 million chronic Hepatitis B carriers.
Dr. Hardik Ahuja is a specialist Hepatologist with dedicated expertise in managing all forms of liver disease — from the earliest stages of fatty liver and viral hepatitis, to complex cirrhosis complications, liver failure, and liver transplant evaluation and post-transplant care.
Most liver diseases are silent in early stages — they cause no symptoms until significant damage has occurred. Early detection through routine liver function tests, ultrasound, and FibroScan can prevent progression to cirrhosis and liver failure.
Hepatic Disorders — Detailed Guide
Fatty Liver Disease (NAFLD / NASH / ALD)
Non-alcoholic, alcoholic, and metabolic fatty liverNon-Alcoholic Fatty Liver Disease (NAFLD) is the most common liver condition in India, affecting 1 in 3 urban adults. It occurs when excess fat accumulates in liver cells in the absence of significant alcohol use. Risk factors include obesity, Type 2 diabetes, high triglycerides, metabolic syndrome, and PCOD.
NASH (Non-Alcoholic Steatohepatitis) is the aggressive form — fat plus inflammation plus liver cell injury — that can progress to fibrosis, cirrhosis, and liver cancer over 10–20 years. Alcoholic Liver Disease (ALD) ranges from fatty liver to alcoholic hepatitis and cirrhosis in heavy drinkers.
Treatment focuses on weight loss (even 5–10% reduces liver fat significantly), dietary modification, blood sugar and lipid control, and in NASH, medications under Dr. Ahuja's supervision. Regular FibroScan monitoring tracks progression.
Jaundice (Hyperbilirubinaemia)
Yellow discolouration of skin and eyes from elevated bilirubinJaundice is not a disease itself but a symptom of an underlying liver, bile duct, or blood condition. It occurs when bilirubin — a breakdown product of red blood cells — accumulates in the blood due to impaired liver processing or bile duct obstruction.
Common causes: Viral hepatitis (A, B, E), gallstones blocking the bile duct, alcoholic liver disease, drug-induced liver injury, haemolytic anaemia, cirrhosis, and pancreatic or bile duct cancer. Neonatal jaundice in newborns requires immediate evaluation.
Dr. Ahuja identifies the exact cause through blood tests (bilirubin fractions, liver enzymes, viral markers), ultrasound, and MRCP or ERCP if bile duct obstruction is suspected. Treatment is directed at the underlying cause.
Hepatitis B (Chronic & Acute)
India has 40 million chronic HBV carriers — the 2nd largest burden globallyHepatitis B Virus (HBV) is transmitted through blood, unprotected sex, or mother-to-child during childbirth. Acute HBV is self-limiting in most adults; however, 5–10% develop chronic infection which, if untreated, leads to cirrhosis (20–30% risk over 20 years) and liver cancer (HCC).
Dr. Ahuja evaluates HBV DNA levels, HBeAg/HBsAg status, liver enzymes, and liver fibrosis stage (FibroScan) to determine who needs antiviral treatment. Tenofovir and Entecavir are highly effective first-line antivirals that suppress HBV DNA and prevent disease progression.
All chronic HBV patients need 6-monthly liver cancer surveillance (AFP + ultrasound). Family members should be screened and vaccinated. Dr. Ahuja provides comprehensive long-term HBV management.
Hepatitis C (HCV — Now Curable)
Direct-acting antivirals cure Hepatitis C in 8–12 weeksHepatitis C Virus (HCV) is spread through blood contact — shared needles, unscreened blood transfusions (pre-1992), or contaminated medical equipment. Unlike Hepatitis B, HCV is now completely curable with Direct-Acting Antiviral (DAA) therapy in 8–12 weeks with a 95%+ cure rate.
Many HCV patients are asymptomatic for decades while the virus silently causes liver fibrosis and cirrhosis. All adults born between 1945–1965 or with risk factors should be screened with a one-time HCV antibody test. Those with positive antibody need HCV RNA PCR to confirm active infection.
Dr. Ahuja prescribes appropriate DAA regimens (Sofosbuvir-based), monitors treatment response, and confirms cure (Sustained Virological Response at 12 weeks after treatment completion). Even patients with advanced cirrhosis can be cured — though transplant may still be needed for end-stage disease.
Hepatitis A & E (Acute Viral Hepatitis)
Waterborne liver infections — common during monsoon in IndiaHepatitis A (HAV) and Hepatitis E (HEV) are transmitted through contaminated food and water — the faeco-oral route. They are especially common during and after monsoon season in India when waterborne contamination increases. Most cases are self-limiting with supportive care.
Symptoms include acute jaundice, fever, nausea, vomiting, dark urine, clay-coloured stools, and right upper abdominal pain. Hepatitis E is particularly dangerous in pregnancy, causing fulminant (rapidly fatal) liver failure in up to 25% of pregnant women — requiring urgent hospital management.
Dr. Ahuja provides supportive management for uncomplicated cases and intensive monitoring for severe or fulminant hepatitis. Hospitalisation is required for inability to eat, coagulopathy, encephalopathy, or fulminant failure. Hepatitis A vaccination is available for prevention.
Liver Cirrhosis & Its Complications
Advanced fibrosis with portal hypertension — requires specialist managementCirrhosis is the end-result of prolonged liver inflammation and fibrosis — where normal liver tissue is replaced by scar tissue, impairing liver function and blood flow. Common causes include chronic Hepatitis B, Hepatitis C, alcohol, and NASH. Cirrhosis can be compensated (no symptoms, liver still functioning) or decompensated (complications present).
Complications of Decompensated Cirrhosis:
• Ascites (fluid in the abdomen) — managed with diuretics and therapeutic paracentesis. • Variceal bleeding (ruptured oesophageal/gastric varices) — prevented by beta-blockers and endoscopic band ligation (EVL). • Hepatic Encephalopathy (brain dysfunction from ammonia) — treated with lactulose and rifaximin. • Spontaneous Bacterial Peritonitis (SBP) — antibiotic treatment. • Hepatorenal Syndrome — intensive medical management.
Dr. Ahuja manages all complications with regular endoscopic surveillance for varices, FibroScan, LFT monitoring, and timely referral for liver transplant when appropriate.
How Liver Disease Progresses — The 5 Stages
Understanding the stages of liver disease is critical. Early intervention at Stages 1–3 can prevent progression to irreversible cirrhosis and liver failure.
Healthy / Steatosis
Fat accumulation only. No inflammation. Fully reversible with lifestyle changes.
Hepatitis / NASH
Fat + inflammation + cell injury. Still reversible with treatment and weight loss.
Fibrosis
Scar tissue forming. Partially reversible. Critical to treat before Stage 4.
Cirrhosis
Extensive scarring. Irreversible but manageable to prevent decompensation.
Liver Failure / HCC
Liver no longer functions. Transplant evaluation required. Cancer screening essential.
Dr. Ahuja's goal: Detect liver disease at Stages 1–3 through routine screening and intervene before irreversible cirrhosis develops. A FibroScan takes 10 minutes and can accurately stage liver fibrosis without a biopsy.
Warning Signs of Liver Disease
Jaundice
Yellow discolouration of skin, eyes (scleral icterus), and dark tea-coloured urine — urgent evaluation needed.
Abdominal Swelling
Fluid accumulation in the abdomen (ascites) — a sign of advanced liver disease or portal hypertension.
Vomiting Blood
Haematemesis from ruptured oesophageal varices — a life-threatening emergency requiring immediate endoscopy.
Confusion / Forgetfulness
Hepatic encephalopathy — brain dysfunction from ammonia build-up in liver failure. Urgent medical attention.
Persistent Fatigue
Unexplained, severe tiredness with loss of appetite and weight — common early symptom of chronic liver disease.
Right Upper Pain
Dull ache or heaviness under the right rib cage — may indicate liver inflammation, fatty liver, or hepatitis.
Emergency signs requiring immediate hospital admission: vomiting blood, severe jaundice with confusion, fever with abdominal pain in cirrhosis patients, or sudden extreme abdomen distension. Call 9990056499 or visit the emergency immediately.
Diagnostic Approach at Dr. Ahuja's Clinic
Clinical History & Examination
Detailed history — alcohol intake, medications, travel, family history, diabetes, obesity. Physical examination for jaundice, liver size, spleen size, ascites, and signs of chronic liver disease (spider naevi, palmar erythema, Dupuytren's contracture).
Blood Tests — Liver Function Panel
Comprehensive biochemical profile to assess liver damage and function.
Ultrasound Abdomen
Non-invasive imaging to assess liver size, echogenicity (fatty liver), bile duct dilation, spleen size, ascites, and focal liver lesions (haemangioma, HCC). Colour Doppler for portal vein flow in suspected portal hypertension.
FibroScan (Transient Elastography)
A 10-minute, painless, non-invasive test that measures liver stiffness — accurately staging liver fibrosis from F0 (normal) to F4 (cirrhosis) without the need for a liver biopsy in most patients. Also measures controlled attenuation parameter (CAP) for fat quantification.
Advanced Imaging (CT / MRI / MRCP)
For characterisation of liver masses (HCC vs benign), bile duct anatomy (MRCP), staging of liver cancer, or pre-transplant evaluation. Triple-phase CT or MRI with contrast is the gold standard for HCC diagnosis.
Upper GI Endoscopy
In cirrhosis patients — to screen for and grade oesophageal and gastric varices (dilated veins from portal hypertension). Endoscopic band ligation (EVL) is performed to prevent variceal bleeding if high-risk varices are found.
Treatment Approaches
🥗 Diet, Weight Loss & Metabolic Control
For NAFLD/NASH — even a 5–10% reduction in body weight reduces liver fat by 30–40% and can reverse early fibrosis. Dr. Ahuja provides structured dietary counselling, physical activity plans, and management of diabetes, lipids, and metabolic syndrome in coordination with an endocrinologist.
💊 Antivirals — HBV & HCV Treatment
Chronic Hepatitis B: Long-term suppression with Tenofovir or Entecavir to prevent cirrhosis and cancer. Hepatitis C: 8–12 week DAA regimen (Sofosbuvir + Velpatasvir or Daclatasvir) — 95%+ cure rate. Dr. Ahuja monitors viral response and manages side effects throughout treatment.
🔄 Cirrhosis Complication Management
Ascites: diuretics (spironolactone, furosemide) and low-sodium diet; large-volume paracentesis with albumin infusion when needed. Hepatic Encephalopathy: lactulose and rifaximin. Variceal bleeding prevention: propranolol and endoscopic band ligation. SBP: prophylactic norfloxacin.
🔬 Endoscopic Procedures for Liver Disease
Endoscopic Variceal Ligation (EVL) to prevent and treat variceal bleeding. ERCP for obstructive jaundice from bile duct stones or strictures. EUS-guided drainage for liver abscesses. These are performed by Dr. Ahuja as part of integrated hepatology care.
🏥 Liver Transplant Evaluation & Post-Transplant Care
Dr. Hardik Ahuja is an LTSI (Liver Transplant Society of India) Fellow 2024, trained at Indraprastha Apollo Hospital, New Delhi. He provides complete transplant hepatology — evaluating patients for liver transplant candidacy, optimising pre-transplant health, and providing long-term post-transplant immunosuppression management and surveillance.
Who Should Get Screened for Liver Disease?
- Adults with obesity (BMI > 25), Type 2 diabetes, or metabolic syndrome — annual LFT and ultrasound
- Anyone born between 1945–1980 with unknown hepatitis status — one-time HCV antibody test
- Healthcare workers, dialysis patients, or those with history of blood transfusions before 1992 — HBsAg and Anti-HCV testing
- Family members of chronic Hepatitis B patients — HBsAg testing and vaccination if negative
- Heavy alcohol consumers (more than 14 units/week men, 7 units/week women) — LFT and ultrasound annually
- Patients on long-term medications (paracetamol, antituberculosis drugs, statins) — periodic LFT monitoring
- All cirrhosis patients — 6-monthly AFP + ultrasound for liver cancer surveillance
- Pregnant women — HBsAg and Anti-HCV screening, especially HEV testing if jaundice occurs